Medical Imaging is the process of allowing users to visualise their digital scans to better understand their prognosis.
The company is focused on its core business of executing its growth strategy and become a...
Paradigm will be focused on Phase 3 trials of its drug Zilosul® during 2021, COO Jeannie Joughin...
The company has created virtual cannabis, with all the characteristics of the real plant,...
Zoetic grows its own hemp and sells CBD products in the US, UK and Europe
The company is well funded and has a strong sales pipeline to launch new devices in home vital...
Orthocell Ltd's (ASX:OCC) Paul Anderson caught up with Proactive's Andrew Scott soon after announcing they've received Food and Drug Administration’s (FDA) 510(k) clearance to market and supply its CelGro collagen medical device for dental bone and tissue regeneration procedures in the US....
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.